|
|
|
| Efficient Soluble Expression of Anti-IgE scFv in E.coli and Optimization of Expression Conditions |
| LIU Qi-gang1,2, DAI Yun-jian2, ZHANG Yong-xia2, WANG Bao-cheng2, WANG Ming-rong2 |
1. Sichuan Industrial Institute of Antibiotics, Chengdu 610052, China;
2. Chengdu Institute of Biological Products Co., Ltd., Chengdu 610023, China |
|
|
|
Abstract Objective: An anti-IgE scFv was used to investigate the influence of different host strains, growth media, and culture conditions on the high-level expression of soluble single-chain antibody fragment in E. coli periplasm. Method: Three engineered bacterial strains, Rosetta (DE3), BL21(DE3), and SoluBL21(DE3), were constructed and effects of different carbon sources, nitrogen sources, growth media, and culture conditions on the amount of expression of soluble anti-IgE scFv were evaluated. Results: The expression level of pET-IgE26, a plasmid that carried anti-IgE scFv sequence, was significantly enhanced in the novel host strain SoluBL21(DE3), compared to that in traditional Rosetta (DE3) and BL21(DE3) host strains. After optimization of carbon and nitrogen sources, growth media and culture conditions, the optimal growth media for high-level expression of soluble recombinant antibodies in SoluBL21(DE3) engineered strain was found to be M9 medium with 0.5% glucose, 0.6% bacto casitone, and 0.02% trace elements. The best culture condition was defined as growing overnight culture in LB medium at 37℃, until OD600 reached approximately 3.0, then inoculate the optimal growth media with the overnight culture at 5% inoculum concentration, shake at 37℃, 260r/min for 3.5h. For induction, lower the temperature to 25℃ when OD600 is between 1.5～1.8, add 0.1mmol/L IPTG, and incubate at 220r/min for 16h. ELISA detected that the expression of soluble anti-IgE scFv increased by 5-fold after optimization. Conclusion: Expression of recombinant scFv in E coli periplasm can be significantly enhanced through optimization of host strain types, growth media, and culture conditions. The study provides technical support for scale-up production of anti-IgE scFv and insights into the production of recombinant micromolecular antibody by E. coli.
|
|
Received: 19 July 2012
Published: 25 November 2012
|
|
|
|
|
[1] Gould H J, Sutton B J. IgE in allergy and asthma today. Nature Reviews Immunology, 2008, 8: 205-217.
[2] Maloney J M, Rudengren M, Ahlstedt S, et al. The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy. The Journal of Allergy and Clinical Immunology, 2008, 122(1): 145-151.
[3] 李明华,殷凯生,朱桂立.哮喘病学.北京:人民卫生出版社,2005.65-75. Li M H, Yin K S, Zhu G L. Asthmology. Beijing:People's Medical Publishing House, 2005.65-75.
[4] Laffer S, Lupinek C, Rauter I, et al. A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells. Allergy, 2008, 63(6):695-702.
[5] Wang M, Zhang Y, Du T, et al. Bacterial expression and characterization of a novel human anti-IgE scFv fragment. MAbs, 2011, 3(5):495-499.
[6] Takayuki O, Miyo A O, et al. Suppression of IgE B Cells and IgE Binding to FcεRI by Gene Therapy with Single-Chain Anti-IgE. The Journal of Immunology, 2009,182(12):8110-8117.
[7] Boushey H A. Experiences with monoclonal antibody therapy for allergic asthma. Allergy Clin Immunol, 2001, 108(Supp 12):S77-S83.
[8] Xiang D, Zhang J, Chen Y, et al. Expressions and purification of a mature form of recombinant human Chemerin in Escherichia coli. Protein Expr Purif, 2010, 69(2):153-158.
[9] Terpe K. Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biot ech nol, 2006, 72(2):211-222.
[10] Wang Z S, Xiang Q J, Wang H Y, et al. Cloning and optimizing expression of a periplasmic solute-binding gene gsiB from Escherichia coli. Journal of Genetics and Genomics, 2010, 32(5):505-511.
[11] Schirrmann T, Al-Halabi L, Dübel S, et al. Production systems for recombinant antibodies. Fronti Biosci, 2008,5(1):4576-4594.
[12] Jordan E, Hust M, Roth A, et al. Production of recombinant antibody fragments in bacillus megaterium. Microbial Cell Fact, 2007, 6: 2.
[13] Paola J, Lorenzo V, Luis A, et al. Thioredoxin fusions Increase folding of single chain Fv antibodies in the cytoplasm of Escherichia coli: evidence that chaperone activity is the prime effect of Thioredoxin. J Mol Biol, 2006, 357(1): 49-61.
[14] Olaofea O A, Burtona S G, Cowan D A, et al. Improving the production of a thermostable amidase through optimising IPTG induction in a highly dense culture of recombinant Escherichia coli. Biochemical Engineering Journal, 2010, 52(1): 19-24. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
